Cashion, C., Li, J., Farina, S., Inam, S., Jeffrey, A., MacDonald, R., Buss, T., Vanguru, V., Boyle, S., Bishop, D., Brown, C., Barraclough, A., Tam, C., Henden, A., Dickinson, M., Blyth, E., Dowling, M. (2025). Real-world outcomes with CAR T-cell therapy for secondary central nervous system lymphoma are similar between patients with active versus historical involvement. Blood. https://doi.org/10.1182/blood-2025-1936